Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 1Liver Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Doxorubicin 8Cisplatin 5Chemotherapy, Adjuvant 5Thalidomide 4Radiofrequency Ablation 4Neoadjuvant Therapy 4Melphalan 4Cyclophosphamide 4Carboplatin 4tremelimumab 3fludarabine 3aldesleukin 3Sorafenib 3Irinotecan 3Capecitabine 3durvalumab 2carotuximab 2Temozolomide 2Tamoxifen 2Oxaliplatin 2Leucovorin 2Gemcitabine 2Fluorouracil 2Fluorodeoxyglucose F18 2Epirubicin 2Cryosurgery 2Biopsy 2Bevacizumab 2sargramostim 1ropidoxuridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Liver Neoplasms × Immunotherapy, Adoptive × Clear all
NCT05003895 2026-04-07

GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
38 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡